The age-standardized incidence rate is 6.6 per 100,000, representing a decreasing trend in global incidence, but with a substantial increase in reported incidence in younger women aged 15–40 [ 1 ].
← all excerpts
Host obesity alters the ovarian tumor immune microenvironment and impacts response to standard of care chemotherapy.
1
—
—